Remove Consulting Remove Information Remove PCP Remove Provider
article thumbnail

What to Expect During a Primary Care Visit

Mesa Family Physician

What to Expect During a Primary Care Visit Visiting a primary care provider for the first time can bring up many questions. What information should you bring? This blog covers everything you need to know—from appointment types and coding to telehealth options and what really happens during your time with the provider.

article thumbnail

Automatic Detection of Osteoporosis in Electronic Consultation (eConsult) Service Using Natural Language Processing [Health care informatics]

Annals of Family Medicine

Context The primary care practitioners’ (PCP) perceptions of disease given patients’ conditions are reflected in their narrated questions to specialists while using eConsult, an online primary care service. We then used pretrained Language Model (BERT) to extract important terms associated with contrasting segments of data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EMS Intervention to Reduce Falls: Carmen Quatman and Katie Quatman-Yates

GeriPal

The insight started when Carmen, an orthopedic surgeon-researcher, and Katie, a physical therapist- researcher participated in ride-alongs with EMS providers to patient’s homes. And yet, after assisting the older adult to their feet, the EMS providers would leave. I think, as providers, we don’t get to see that.

Community 114
article thumbnail

DEA Proposes Additions to Longstanding Precursor Chemical Special Surveillance List

FDA Law

The Comprehensive Methamphetamine Control Act of 1996 (“MCA”) amended the Controlled Substances Act (“CSA”) by providing for the Attorney General to publish a Special Surveillance List of chemicals and other “laboratory supplies” used in the clandestine manufacture of controlled substances. 21 U.S.C. § 39,479, (June 16, 2023).

article thumbnail

DEA Cranks Out Updated Special Surveillance List and Proposed Regulatory Actions

FDA Law

DEA publishes the Special Surveillance List to inform about potential illicit uses of a laboratory supply and reminds that civil penalties may be imposed on businesses that distribute a laboratory supply with reckless disregard for the illegal uses to which it will be put. 21 U.S.C. § 21 U.S.C. § 842(a)(11).